Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations have been made in mice with and without peripheral artery disease (PAD), and also in humans where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was found also to augment perfusion by almost 2-fold. The latter human studies were performed with ultrasound protocols designed for perfusion imaging and not for flow augmentation. In this study, we will measure the degree to which limb perfusion is augmented with specific therapeutic CEU settings that are still within the FDA-approved limits with regards to US power and contrast dosing.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Ultrasound exposure of Definity microbubbles infused over 10 min. Ultrasound administered at 1.3 MHz, mechanical index of 1.3, and pulsing interval of 10 s.
OHSU
Portland, Oregon, United States
RECRUITINGChange in blood flow at 10 min
Change in blood flow in calf skeletal muscle
Time frame: 10 min post-therapeutic ultrasound cavitation.
Change in blood flow at 60 min
Change in blood flow in calf skeletal muscle
Time frame: 60 min post-therapeutic ultrasound cavitation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.